Premium
Treatment of metastatic adrenal cortical carcinoma with cisplatin and etoposide (VP‐16)
Author(s) -
Johnson David H.,
Anthony Greco F.
Publication year - 1986
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/1097-0142(19861115)58:10<2198::aid-cncr2820581006>3.0.co;2-a
Subject(s) - mitotane , medicine , etoposide , cisplatin , adrenocortical carcinoma , adrenal cortex , carcinoma , oncology , metastatic carcinoma , chemotherapy
Two patients with metastatic adrenal cortical carcinoma were treated with cisplatin and etoposide. Both achieved a partial remission after only one cycle. One patient had a „nonfunctioning” tumor that had previously regressed on mitotane whereas the second patient presented with classical Cushing's syndrome. Although the latter patient's urinary 17‐ketosteroids normalized while receiving mitotane, the tumor itself failed to regress objectively. Cisplatin plus etoposide appears to be an active combination for the treatment of metastatic adrenal cortical carcinoma.